Skip to main content
logo
Lifecore Biomedical logo
Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.44
+0.01 (0.23%)
Oct 14, 2026, 9:53 AM EDT - Market open

Lifecore Biomedical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 May '25 May '24 May '23 May '22
Revenue
129.46129.46128.87128.26103.27111.27
Revenue Growth
0.80%0.46%0.47%24.20%-7.19%10.31%
Gross Profit
40.6140.6140.341.8527.9939.07
Operating Income
-1.26-1.26-12.01-5.49-19.72-3.43
Net Income
-34.5-34.5-44.3612.01-99.56-116.72
Earnings Per Share
-0.93-0.93-1.270.33-3.32-3.97
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 May '25 May '24 May '23 May '22
Cash & Investments
17.4717.478.278.4619.090.99
Total Debt
143.73143.73130.82128.63112.62150.2
Net Cash (Debt)
-126.26-126.26-122.56-120.17-93.53-149.21
Net Cash Growth
------
Net Cash Per Share
-3.38-3.38-3.52-3.28-3.12-5.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 May '25 May '24 May '23 May '22
Operating Cash Flow
12.5712.57-0.210.26-17.44-22.59
Capital Expenditures
-6.34-6.34-13.42-18.4-21.48-29.94
Free Cash Flow
6.236.23-13.62-18.14-38.92-52.53
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 May '25 May '24 May '23 May '22
Gross Margin
31.37%31.37%31.27%32.63%27.10%35.11%
Operating Margin
-0.97%-0.97%-9.32%-4.28%-19.10%-3.08%
Pretax Margin
-23.34%-23.34%-30.01%7.42%-61.90%-18.59%
Profit Margin
-26.65%-26.65%-34.42%9.37%-96.41%-104.89%
FCF Margin
4.81%4.81%-10.57%-14.14%-37.69%-47.21%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Dec '25 May '25 May '24 May '23 May '22
PE Ratio
---14.29--
Forward PE
-8.178.1725.55167.00250.59
P/FCF Ratio
39.0149.20----
PS Ratio
1.882.371.931.342.332.62